Barcelona, Spain: Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research presented at the 3rd ESTRO Forum in Barcelona, Spain, on Sunday. Brachytherapy is a type of internal radiotherapy that involves putting a […]
Category: Cancer
Combined brachytherapy techniques should be “benchmark” for cervical cancer treatment
Barcelona, Spain: The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers higher radiation doses to the tumour without an increase in treatment-related problems afterwards. Brachytherapy is a type of internal radiotherapy that involves putting a […]
New radiotracer helps avoid neck dissection in patients with early head and neck cancer
Nice, France: The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. Now a team of researchers has been able to identify accurately the sentinel node (SN) in head and […]
New research shows possibility of cure for HPV positive throat cancer patients with limited distant metastasis
Nice, France: Patients with cancer of the throat caused by the Human Papilloma virus (HPV+) have a better prognosis than those who are negative for the virus (HPV-). Now, for the first time, researchers have shown with convincing evidence that a group of patients with HPV+ cancer of the oropharynx (the part of the throat […]
Sugary drinks linked to earlier onset of menstrual periods
Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to new research published online in Human Reproduction [1], one of the world’s leading reproductive medicine journals. In the first study to look at the relation between sugar-sweetened drinks and the age at which girls have […]
Lung cancer predicted to overtake breast cancer as leading cause of cancer death among European women in 2015
Death rates from lung cancer will exceed those for breast cancer for the first time among European women in 2015, according to the latest predictions published in the leading cancer journal Annals of Oncology [1]. The study by researchers in Italy and Switzerland predicts that although the actual number of deaths from all cancers in […]
Early results of new drug, ASP8273, show response in Japanese patients with treatment-resistant non-small cell lung cancer
Barcelona, Spain: In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers told the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, that an oral drug called ASP8273 has caused tumour shrinkage in patients in a […]
Three drugs may be better than one for certain patients with advanced colorectal cancer
Barcelona, Spain: Patients with a form of advanced colorectal cancer that is driven by a mutated version of the BRAF gene have limited treatment options available. However, results from a multi-centre clinical trial suggest that the cancer may respond to a combination of three targeted drugs. Professor Josep Tabernero, head of the medical oncology department […]
Researchers pioneer new approach to treating HPV-related cervical cancer
Barcelona, Spain: A drug that is already well established as a treatment for infection of the retina in people with AIDS has been shown, for the first time, to sensitise cervical cancer to chemotherapy and radiotherapy without an increase in toxic side-effects. Cidofovir is an anti-viral drug that is effective against several viruses, including the […]
Early results show response to new drug in patients with lymphomas and advanced solid tumours
Barcelona, Spain: Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial. Preliminary results from the trial were presented on Thursday at the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in […]